Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Hikma Pharmaceuticals PLC
9435Current price
30 910 JPY
0 JPY (0.00%)
Last closed
1 855 GBX
Company
www.hikma.com
ISIN
GB00B0LCW083
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Tokyo Stock Exchange
Capitalization
4 258 565 400 GBX
Yield for 12 month
+3.80 %
1Y
3Y
5Y
10Y
15Y
9435
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom. Address: 1 New Burlington Place, London, United Kingdom, W1S 2HR
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 794.82 GBXP/E ratio
28.3788Dividend Yield
4.18 %Current Year
+222 514 650 000 GBX
Last Year
+194 806 738 800 GBX
Current Quarter
+121 434 951 600 GBX
Last Quarter
+112 069 987 200 GBX
Current Year
+107 580 996 000 GBX
Last Year
+97 906 446 000 GBX
Current Quarter
+58 511 678 400 GBX
Last Quarter
+53 558 308 800 GBX
Key Figures 9435
1 year
3 years
5 years
10 years
EBITDA
844 000 002 GBX
Operating Margin TTM
PE Ratio
28.3788
Return On Assets TTM
9.4 %
PEG Ratio
2.3791
Return On Equity TTM
12.88 %
Wall Street Target Price
1 794.82 GBX
Revenue TTM
3 016 999 936 GBX
Book Value
10.31 GBX
Revenue Per Share TTM
Dividend Share
0.79 GBX
Quarterly Revenue Growth YOY
10 %
Dividend Yield
4.18 %
Gross Profit TTM
1 265 000 000 GBX
Earnings per share
0.66 GBX
Diluted Eps TTM
0.66 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
71.2 %
Profit Margin
9.45 %
Dividend Analytics 9435
Dividend growth over 5 years
77 %Continuous growth
7 yearsPayout Ratio 5 years average
54 %Dividend History 9435
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.62
Ex Dividend Date
15.08.2024
Forward Annual Dividend Yield
3.32 %
Last Split Factor
1:1
Payout Ratio
72.75 %
Last Split Date
04.09.2013
Dividend Date
–
Stock Valuation 9435
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
28.3788
Forward PE
12.0337
Enterprise Value Revenue
2.1897
Price Sales TTM
1.4115
Enterprise Value EBITDA
11.4048
Price Book MRQ
2.4265
Financials 9435
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 9435
For 52 weeks
1 644.13 GBX
2 114 GBX
50 Day MA
1 938.6 GBX
Shares Short Prior Month
–
200 Day MA
1 923.28 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart